Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-11-03

Clinical Trial Update: Gemcitabine, Infusional 5 Fluorouracil and Bevacizumab in Patients With Advanced Pancreas Cancer [Phase 2]

View source ↗

Summary

This is a Phase 2 trial evaluating gemcitabine plus infusional 5-fluorouracil and bevacizumab in advanced pancreatic cancer; results have been posted after comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 5-Fluorouracil (5-FU)
  • Avastin (bevacizumab)
  • Gemzar (gemcitabine)

Snippet

Sponsor: Tony Bekaii-Saab | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-11-03